The present invention relates to methods and compositions useful in treating subterranean formations, and more particularly, to consolidating relatively unconsolidated portions of subterranean formations and minimizing the flow back of unconsolidated particulate material (referred to collectively herein as “particulate migration”). This invention also relates to modifying the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations.
In the production of hydrocarbons from a subterranean formation, the subterranean formation preferably should be sufficiently conductive to permit desirable fluids, such as oil and gas, to flow to a well bore that penetrates the formation. One type of treatment that may be used to increase the conductivity of a subterranean formation is hydraulic fracturing. Hydraulic fracturing operations generally involve pumping a treatment fluid (e.g., a fracturing fluid or a “pad” fluid) into a well bore that penetrates a subterranean formation at a sufficient hydraulic pressure to create or enhance one or more fractures in the subterranean formation. The fluid used in the treatment may comprise particulates, often referred to as “proppant particulates,” that are deposited in the resultant fractures. These proppant particulates are thought to prevent the fractures from fully closing upon the release of hydraulic pressure, forming conductive channels through which fluids may flow to a well bore. The term “propped fracture” as used herein refers to a fracture (naturally-occurring or otherwise) in a portion of a subterranean formation that contains at least a plurality of proppant particulates. The term “proppant pack” refers to a collection of proppant particulates within a fracture.
A type of particulate migration that may affect fluid conductivity in the formation is the flow back of unconsolidated particulate material (e.g., formation fines, proppant particulates, etc.) through the conductive channels in the subterranean formation, which can, for example, clog the conductive channels and/or damage the interior of the formation or equipment. There are several known techniques used to control particulate migration, some of which may involve the use of consolidating agents. The term “consolidating agent” as used herein includes any compound that is capable of minimizing particulate migration in a subterranean formation and/or modifying the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations.
One well-known technique used to control particulate migration in subterranean formations is commonly referred to as “gravel packing,” which involves the placement of a filtration bed of gravel particulates in the subterranean formation, which acts as a barrier to prevent particulates from flowing into the well bore. These gravel packing operations may involve the use of consolidating agents to bind the gravel particulates together in order to form a porous matrix through which formation fluids can pass.
Another technique that may be used to control particulate migration involves coating proppant particulates with a consolidating agent to facilitate their consolidation within the formation and to prevent their subsequent flow-back through the conductive channels in the subterranean formation.
Another method used to control particulate migration involves consolidating unconsolidated portions of subterranean zones into relatively stable permeable masses by applying a consolidating agent to an unconsolidated portion of the subterranean formation. One example of this method is applying a curable resin to a portion of the zone, followed by a spacer fluid and then a catalyst. Another example of this method involves applying a tackifying composition (aqueous or non-aqueous) to a portion of the formation in an effort to reduce the migration of particulates therein. Whereas a curable resin composition produces a hard mass, the use of a tackifying composition produces a more malleable consolidated mass.
Although consolidating agents are used frequently, they may be difficult to handle, transport and clean-up due to their inherent tendency to stick to equipment or anything else with which they may come into contact. Therefore, it would be desirable to provide compositions and methods that would, among other things, help ease the handling, transport and clean up when using consolidating agents.
One additional problem that can negatively impact conductivity and further complicate the effects of particulate migration is the tendency of mineral surfaces in a subterranean formation to undergo chemical reactions caused, at least in part, by conditions created by mechanical stresses on those minerals (e.g., fracturing of mineral surfaces, compaction of mineral particulates). These reactions are herein referred to as “stress-activated reactions” or “stress-activated reactivity.” As used herein, the term “mineral surface in a subterranean formation” and derivatives thereof refer to any surface in a subterranean formation comprised of minerals and/or the surface of a particulate. These minerals may comprise any mineral found in subterranean formations, including silicate minerals (e.g., quartz, feldspars, clay minerals), carbonaceous minerals, metal oxide minerals, and the like. The mineral surface in a subterranean formation treated in the methods of the present invention may have been formed at any time. The term “modifying the stress-activated reactivity of a mineral surface” and its derivatives as used herein refers to increasing or decreasing the tendency of a mineral surface in a subterranean formation to undergo one or more stress-activated reactions, or attaching a compound to the mineral surface that is capable of participating in one or more subsequent reactions with a second compound.
One type of reaction caused, at least in part, by conditions created by mechanical stresses on minerals is a diageneous reaction. As used herein, the terms “diageneous reaction,” “diageneous reactivity,” and “diagenesis” are defined to include chemical and physical processes that move a portion of a mineral sediment and/or convert the mineral sediment into some other mineral form in the presence of water. A mineral sediment that has been so moved or converted is herein referred to as a “diageneous product.” Any mineral sediment may be susceptible to these diageneous reactions, including silicate minerals (e.g., quartz, feldspars, clay minerals), carbonaceous minerals, metal oxide minerals, and the like.
Two of the principle mechanisms that diageneous reactions are thought to involve are pressure solution and precipitation processes. Where two water-wetted mineral surfaces are in contact with each other at a point under strain, the localized mineral solubility near that point is thought to increase, causing the minerals to dissolve. Minerals in solution may diffuse through the water film outside of the region where the mineral surfaces are in contact (e.g., in the pore spaces of a proppant pack), where they may precipitate out of solution. The dissolution and precipitation of minerals in the course of these reactions may reduce the conductivity of the formations by, among other things, clogging the conductive channels in the formation with mineral precipitate and/or collapsing those conductive channels by dissolving solid minerals in the surfaces of those channels.
Moreover, in the course of a fracturing treatment, new mineral surfaces may be created in the “walls” surrounding the open space of the fracture. These new walls created in the course of a fracturing treatment are herein referred to as “fracture faces.” Such fracture faces may exhibit different types and levels of reactivity, for example, stress-activated reactivity. In some instances, fracture faces may exhibit an increased tendency to undergo diageneous reactions. In other instances, fracture faces also may exhibit an increased tendency to react with substances in formation fluids and/or treatment fluids that are in contact with those fracture faces, such as water, polymers (e.g., polysaccharides, biopolymers, etc.), and other substances commonly found in these fluids, whose molecules may become anchored to the fracture face. This reactivity may further decrease the conductivity of the formation through, inter alia, increased diageneous reactions and/or the obstruction of conductive fractures in the formation by any molecules that have become anchored to the fracture faces.
Therefore, what is desirable is a means for minimizing particulate migration and diagenesis reactions within a subterranean formation that would allow for efficient and relatively easy handling, transportation and clean up.
The present invention relates to methods and compositions useful for minimizing particulate migration. This invention also relates to modifying the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations.
In some embodiments, the present invention provides a method comprising the steps of: providing a consolidating agent emulsion composition that comprises an aqueous fluid, a surfactant, and a consolidating agent; and coating at least a plurality of particulates with the consolidating agent emulsion to produce a plurality of consolidating agent emulsion coated particulates.
In other embodiments, the present invention provides a method comprising the steps of: providing a treatment fluid comprising a consolidating agent emulsion comprising an aqueous fluid, an amine surfactant, and a consolidating agent; and introducing the treatment fluid into a subterranean formation.
In other embodiments, the present invention provides a method comprising the steps of: coating a plurality of particulates with a consolidating agent emulsion to produce consolidating agent emulsion coated particulates; providing a treatment fluid comprising an aqueous fluid, a surfactant, and a consolidating agent; introducing the treatment fluid into a subterranean formation.
In other embodiments, the present invention provides a consolidating agent emulsion composition comprising: an aqueous fluid; a surfactant; and a consolidating agent comprising a non-aqueous tackifying agent or resin.
The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
These drawings illustrate certain aspects of some of the embodiments of the present invention, and should not be used to limit or define the invention.
The present invention relates to methods and compositions useful for minimizing particulate migration. This invention also relates to modifying the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations. One of the many advantages of the consolidating agent emulsions of the present invention is that they may enhance the efficiency and ease of using consolidating agents by allowing for, inter alia, relatively easy clean up of equipment and reduced potential damage to equipment due to the buildup of the consolidation agent on the equipment. In some embodiments, the consolidating agent emulsions of the present invention may also eliminate the need for an expensive and/or flammable solvent that might otherwise be necessary when using consolidating agents and may thereby reduce possible undesirable environmental concerns related to the use and disposal of such solvents.
A. The Consolidating Agent Emulsions of the Present Invention
The consolidating agent emulsions of the present invention comprise an aqueous fluid, a surfactant, and a consolidating agent. These consolidating agent emulsions have water external phases and oil internal phases.
1. Suitable Aqueous Fluids
Suitable aqueous fluids that may be used in the consolidating agent emulsions of the present invention include fresh water, salt water, brine, seawater, or any other aqueous fluid that, preferably, does not adversely react with the other components used in accordance with this invention or with the subterranean formation. One should note, however, that if long-term stability of the emulsion is desired, the preferred aqueous fluid is one that is substantially free of salts. It is within the ability of one skilled in the art with the benefit of this disclosure to determine if and how much salt may be tolerated in the consolidating agent emulsions of the present invention before it becomes problematic for the stability of the emulsion. The aqueous fluid preferably is present in the consolidating agent emulsions of the present invention in an amount in the range from about 40% to 80% by weight of the consolidating agent emulsion composition.
2. Suitable Types of Consolidating Agents
The consolidating agents used in the compositions and methods of the present invention generally comprise any compound that is capable of minimizing particulate migration and/or modifying the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations. The consolidating agent may comprise compounds such as non-aqueous tackifying agents or resins. The consolidating agents may be present in the consolidating agent emulsions of the present invention in an amount in the range from about 5% to 95% by weight of the composition. Preferably, the consolidating agent is present in the consolidating agent emulsions of the present invention in an amount in the range from about 15% to 50% by weight of the composition. The type and amount of consolidating agent included in a particular composition or method of the invention may depend upon, among other factors, the temperature of the subterranean formation, the chemical composition of formations fluids, flow rate of fluids present in the formation, and the like. It is within the ability of one skilled in the art, with the benefit of this disclosure, to determine the type and amount of consolidating agent to include in the consolidating agent emulsions of the present invention to achieve the desired results.
a. Non-Aqueous Tackifying Agents
In some embodiments of the present invention, the consolidating agent may comprise a non-aqueous tackifying agent. A particularly preferred group of non-aqueous tackifying agents comprises polyamides that are liquids or in solution at the temperature of the subterranean formation such that they are, by themselves, non-hardening when introduced into the subterranean formation. A particularly preferred product is a condensation reaction product comprised of commercially available polyacids and a polyamine. Such commercial products include compounds such as mixtures of C36 dibasic acids containing some trimer and higher oligomers and also small amounts of monomer acids that are reacted with polyamines. Other polyacids include trimer acids, synthetic acids produced from fatty acids, maleic anhydride, acrylic acid, and the like. Such acid compounds are commercially available from companies such as Witco Corporation, Union Camp, Chemtall, and Emery Industries. The reaction products are available from, for example, Champion Technologies, Inc. and Witco Corporation.
Additional compounds which may be used as non-aqueous tackifying agents include liquids and solutions of, for example, polyesters, polycarbonates and polycarbamates, natural resins such as shellac and the like.
Other suitable non-aqueous tackifying agents are described in U.S. Pat. No. 5,853,048 issued to Weaver, et al. and U.S. Pat. No. 5,833,000 issued to Weaver, et al., the relevant disclosures of which are herein incorporated by reference.
Non-aqueous tackifying agents suitable for use in the present invention may either be used such that they form a non-hardening coating or they may be combined with a multifunctional material capable of reacting with the non-aqueous tackifying agent to form a hardened coating. A “hardened coating” as used herein means that the reaction of the tackifying compound with the multifunctional material will result in a substantially non-flowable reaction product that exhibits a higher compressive strength in a consolidated agglomerate than the tackifying compound alone with the particulates. In this instance, the non-aqueous tackifying agent may function similarly to a hardenable resin.
Multifunctional materials suitable for use in the present invention include, but are not limited to, aldehydes, dialdehydes such as glutaraldehyde, hemiacetals or aldehyde releasing compounds, diacid halides, dihalides such as dichlorides and dibromides, polyacid anhydrides such as citric acid, epoxides, furfuraldehyde, glutaraldehyde, aldehyde condensates, and silyl-modified polyamide compounds and the like, and combinations thereof. Suitable silyl-modified polyamide compounds that may be used in the present invention are those that are substantially self-hardening compositions capable of at least partially adhering to particulates in the unhardened state, and that are further capable of self-hardening themselves to a substantially non-tacky state to which individual particulates such as formation fines will not adhere to, for example, in formation or proppant pack pore throats. Such silyl-modified polyamides may be based, for example, on the reaction product of a silating compound with a polyamide or a mixture of polyamides. The polyamide or mixture of polyamides may be one or more polyamide intermediate compounds obtained, for example, from the reaction of a polyacid (e.g., diacid or higher) with a polyamine (e.g., diamine or higher) to form a polyamide polymer with the elimination of water.
In some embodiments of the present invention, the multifunctional material may be mixed with the tackifying compound in an amount of from about 0.01% to about 50% by weight of the tackifying compound to effect formation of the reaction product. In other embodiments, the compound is present in an amount of from about 0.5% to about 1% by weight of the tackifying compound. Suitable multifunctional materials are described in U.S. Pat. No. 5,839,510 issued to Weaver, et al., the relevant disclosure of which is herein incorporated by reference.
b. Resins
In some embodiments of the present invention, the consolidating agent may comprise a resin. The term “resin” as used herein refers to any of numerous physically similar polymerized synthetics or chemically modified natural resins including thermoplastic materials and thermosetting materials. Resins suitable for use in the present invention include all resins known and used in the art. One type of resin coating material suitable for use in the compositions and methods of the present invention is a two-component epoxy based resin comprising a liquid hardenable resin component and a liquid hardening agent component. The liquid hardenable resin component is comprised of a hardenable resin and an optional solvent. The solvent may be added to the resin to reduce its viscosity for ease of handling, mixing and transferring. It is within the ability of one skilled in the art with the benefit of this disclosure to determine if and how much solvent may be needed to achieve a viscosity suitable to the subterranean conditions. Factors that may affect this decision include geographic location of the well, the surrounding weather conditions, and the desired long-term stability of the consolidating agent emulsion. An alternate way to reduce the viscosity of the hardenable resin is to heat it. This method avoids the use of a solvent altogether, which may be desirable in certain circumstances. The second component is the liquid hardening agent component, which is comprised of a hardening agent, a silane coupling agent, a surfactant, an optional hydrolyzable ester for, among other things, breaking gelled fracturing fluid films on the proppant particulates, and an optional liquid carrier fluid for, among other things, reducing the viscosity of the hardening agent component.
Examples of hardenable resins that can be used in the liquid hardenable resin component include, but are not limited to, organic resins such as bisphenol A diglycidyl ether resin, butoxymethyl butyl glycidyl ether resin, bisphenol A-epichlorohydrin resin, bisphenol F resin, polyepoxide resin, novolak resin, polyester resin, phenol-aldehyde resin, urea-aldehyde resin, furan resin, urethane resin, a glycidyl ether resin, other similar epoxide resins and combinations thereof. The hardenable resin used is included in the liquid hardenable resin component in an amount in the range of from about 5% to about 100% by weight of the liquid hardenable resin component. In some embodiments the hardenable resin used is included in the liquid hardenable resin component in an amount of about 25% to about 55% by weight of the liquid hardenable resin component. It is within the ability of one skilled in the art with the benefit of this disclosure to determine how much of the liquid hardenable resin component may be needed to achieve the desired results. Factors that may affect this decision include which type of liquid hardenable resin component and liquid hardening agent component are used.
Any solvent that is compatible with the hardenable resin and achieves the desired viscosity effect may be suitable for use in the liquid hardenable resin component. Suitable solvents may include butyl lactate, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, diethyleneglycol butyl ether, propylene carbonate, methanol, butyl alcohol, d'limonene, fatty acid methyl esters, and combinations thereof. Other preferred solvents may include aqueous dissolvable solvents such as, methanol, isopropanol, butanol, glycol ether solvents, and combinations thereof. Suitable glycol ether solvents include, but are not limited to, diethylene glycol methyl ether, dipropylene glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanol containing at least one C1 to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, hexoxyethanol, and isomers thereof. Selection of an appropriate solvent is dependent on the resin composition chosen and is within the ability of one skilled in the art with the benefit of this disclosure.
As described above, use of a solvent in the liquid hardenable resin component is optional but may be desirable to reduce the viscosity of the hardenable resin component for ease of handling, mixing, and transferring. It is within the ability of one skilled in the art, with the benefit of this disclosure, to determine if and how much solvent is needed to achieve a suitable viscosity. In some embodiments, the amount of the solvent used in the liquid hardenable resin component may be in the range of from about 0.1% to about 30% by weight of the liquid hardenable resin component. Optionally, the liquid hardenable resin component may be heated to reduce its viscosity, in place of, or in addition to, using a solvent.
Examples of the hardening agents that can be used in the liquid hardening agent component include, but are not limited to, piperazine, derivatives of piperazine (e.g., aminoethylpiperazine), 2H-pyrrole, pyrrole, imidazole, pyrazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, 3H-indole, indole, 1H-indazole, purine, 4H-quinolizine, quinoline, isoquinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, 4H-carbazole, carbazole, β-carboline, phenanthridine, acridine, phenathroline, phenazine, imidazolidine, phenoxazine, cinnoline, pyrrolidine, pyrroline, imidazoline, piperidine, indoline, isoindoline, quinuclindine, morpholine, azocine, azepine, 2H-azepine, 1,3,5-triazine, thiazole, pteridine, dihydroquinoline, hexa methylene imine, indazole, amines, aromatic amines, polyamines, aliphatic amines, cyclo-aliphatic amines, amides, polyamides, 2-ethyl-4-methyl imidazole, 1,1,3-trichlorotrifluoroacetone, and combinations thereof. The chosen hardening agent often effects the range of temperatures over which a hardenable resin is able to cure. By way of example and not of limitation, in subterranean formations having a temperature from about 60° F. to about 250° F., amines and cyclo-aliphatic amines such as piperidine, triethylamine, N,N-dimethylaminopyridine, benzyldimethylamine, tris(dimethylaminomethyl)phenol, and 2-(N2N-dimethylaminomethyl)phenol are preferred with N,N-dimethylaminopyridine most preferred. In subterranean formations having higher temperatures, 4,4′-diaminodiphenyl sulfone may be a suitable hardening agent. Hardening agents that comprise piperazine or a derivative of piperazine have been shown capable of curing various hardenable resins from temperatures as low as about 70° F. to as high as about 350° F. The hardening agent used may be included in the liquid hardening agent component in an amount sufficient to consolidate the coated particulates. In some embodiments of the present invention, the hardening agent used is included in the liquid hardening agent component in the range of from about 5% to about 95% by weight of the liquid hardening agent component. In other embodiments, the hardening agent used may be included in the liquid hardening agent component in an amount of about 15% to about 85% by weight of the liquid hardening agent component. In other embodiments, the hardening agent used may be included in the liquid hardening agent component in an amount of about 15% to about 55% by weight of the liquid hardening agent component.
The silane coupling agent may be used, among other things, to act as a mediator to help bond the resin to formation particulates and-or proppant. Examples of suitable silane coupling agents include, but are not limited to, N-β-(aminoethyl)-γ-aminopropyl trimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, and combinations thereof. The silane coupling agent used is included in the liquid hardening agent component in an amount capable of sufficiently bonding the resin to the particulate. In some embodiments of the present invention, the silane coupling agent used is included in the liquid hardening agent component in the range of from about 0.1% to about 3% by weight of the liquid hardening agent component.
Any surfactant compatible with the hardening agent and capable of facilitating the coating of the resin onto particulates in the subterranean formation may be used in the liquid hardening agent component. Such surfactants include, but are not limited to, an alkyl phosphonate surfactant (e.g., a C12-C22 alkyl phosphonate surfactant), an ethoxylated nonyl phenol phosphate ester, one or more cationic surfactants, and one or more nonionic surfactants. Mixtures of one or more cationic and nonionic surfactants also may be suitable. Examples of such surfactant mixtures are described in U.S. Pat. No. 6,311,773 issued to Todd et al. on Nov. 6, 2001, the relevant disclosure of which is incorporated herein by reference. The surfactant or surfactants that may be used are included in the liquid hardening agent component in an amount in the range of from about 1% to about 10% by weight of the hardening agent component.
While not required, examples of hydrolyzable esters that may be used in the liquid hardening agent component include, but are not limited to, a mixture of dimethylglutarate, dimethyladipate, and dimethylsuccinate; dimethylthiolate; methyl salicylate; dimethyl salicylate; dimethylsuccinate; t-butylhydroperoxide; and combinations thereof. When used, a hydrolyzable ester is included in the liquid hardening agent component in an amount in the range of from about 0.1% to about 3% by weight of the liquid hardening agent component. In some embodiments a hydrolyzable ester is included in the liquid hardening agent component in an amount in the range of from about 1% to about 2.5% by weight of the liquid hardening agent component.
Use of a diluent or liquid carrier fluid in the hardenable resin composition is optional and may be used to reduce the viscosity of the hardenable resin component for ease of handling, mixing and transferring. Any suitable carrier fluid that is compatible with the hardenable resin and achieves the desired viscosity effects is suitable for use in the present invention. Some suitable liquid carrier fluids are those having high flash points (e.g., about 125° F.) because of, among other things, environmental and safety concerns; such solvents include, but are not limited to, butyl lactate, butylglycidyl ether, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, diethyleneglycol butyl ether, propylene carbonate, methanol, butyl alcohol, d'limonene, fatty acid methyl esters, and combinations thereof. Other suitable liquid carrier fluids include aqueous dissolvable solvents such as, for example, methanol, isopropanol, butanol, glycol ether solvents, and combinations thereof. Suitable glycol ether liquid carrier fluids include, but are not limited to, diethylene glycol methyl ether, dipropylene glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanol having at least one C1 to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, hexoxyethanol, and isomers thereof. Selection of an appropriate liquid carrier fluid is dependent on, inter alia, the resin composition chosen.
Another resin suitable for use in the methods of the present invention are furan-based resins. Suitable furan-based resins include, but are not limited to, furfuryl alcohol resins, mixtures furfuryl alcohol resins and aldehydes, and a mixture of furan resins and phenolic resins. Of these, furfuryl alcohol resins are preferred. A furan-based resin may be combined with a solvent to control viscosity if desired. Suitable solvents for use in the furan-based consolidation fluids of the present invention include, but are not limited to 2-butoxy ethanol, butyl lactate, butyl acetate, tetrahydrofurfuryl methacrylate, tetrahydrofurfuryl acrylate, esters of oxalic, maleic and succinic acids, and furfuryl acetate. Of these, 2-butoxy ethanol is preferred.
Still another resin suitable for use in the methods of the present invention is a phenolic-based resin. Suitable phenolic-based resins include, but are not limited to, terpolymers of phenol, phenolic formaldehyde resins, and a mixture of phenolic and furan resins. Of these, a mixture of phenolic and furan resins is preferred. A phenolic-based resin may be combined with a solvent to control viscosity if desired. Suitable solvents for use in the phenolic-based consolidation fluids of the present invention include, but are not limited to butyl acetate, butyl lactate, furfuryl acetate, and 2-butoxy ethanol. Of these, 2-butoxy ethanol is preferred.
Yet another resin-type coating material suitable for use in the methods of the present invention is a phenol/phenol formaldehyde/furfuryl alcohol resin comprising from about 5% to about 30% phenol, from about 40% to about 70% phenol formaldehyde, from about 10 to about 40% furfuryl alcohol, from about 0.1% to about 3% of a silane coupling agent, and from about 1% to about 15% of a surfactant. In the phenol/phenol formaldehyde/furfuryl alcohol resins suitable for use in the methods of the present invention, suitable silane coupling agents include, but are not limited to, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, and n-beta-(aminoethyl)-gamma-aminopropyltrimethoxysilane. Suitable surfactants include, but are not limited to, an ethoxylated nonyl phenol phosphate ester, mixtures of one or more cationic surfactants, and one or more non-ionic surfactants and an alkyl phosphonate surfactant.
2. Suitable Types of Surfactants
Surfactants suitable for use in the present invention are those capable of emulsifying an oil based component in a water-based component so that the emulsion has a water external phase and an oil internal phase. A preferred surfactant is an amine surfactant. Such preferred amine surfactants include, but are not limited to, amine ethoxylates and amine ethoxylated quaternary salts such as tallow diamine and tallow triamine exthoxylates and quaternary salts. Examples of suitable surfactants are ethoxylated C12-C22 diamine, ethoxylated C12-C22 triamine, ethoxylated C12-C22 tetraamine, ethoxylated C12-C22 diamine methylchloride quat, ethoxylated C12-C22 triamine methylchloride quat, ethoxylated C12-C22 tetraamine methylchloride quat, ethoxylated C12-C22 diamine reacted with sodium chloroacetate, ethoxylated C12-C22 triamine reacted with sodium chloroacetate, ethoxylated C12-C22 tetraamine reacted with sodium chloroacetate, ethoxylated C12-C22 diamine acetate salt, ethoxylated C12-C22 diamine hydrochloric acid salt, ethoxylated C12-C22 diamine glycolic acid salt, ethoxylated C12-C22 diamine DDBSA salt, ethoxylated C12-C22 triamine acetate salt, ethoxylated C12-C22 triamine hydrochloric acid salt, ethoxylated C12-C22 triamine glycolic acid salt, ethoxylated C12-C22 triamine DDBSA salt, ethoxylated C12-C22 tetraamine acetate salt, ethoxylated C12-C22 tetraamine hydrochloric acid salt, ethoxylated C12-C22 tetraamine glycolic acid salt, ethoxylated C12-C22 tetraamine DDBSA salt, pentamethylated C12-C22 diamine quat, heptamethylated C12-C22 diamine quat, nonamethylated C12-C22 diamine quat, and combinations thereof.
In some embodiments of the present invention the amine surfactant may have the general formula:
wherein R is a C12-C22 aliphatic hydrocarbon; R′ is independently selected from hydrogen or C1 to C3 alkyl group; A is NH or O, and x+y has a value greater than or equal to one but also less than or equal to three. Preferably the R group is a non-cyclic aliphatic. In some embodiments the R group contains at least one degree of unsaturation that is to say at least one carbon-carbon double bond. In other embodiments the R group may be a commercially recognized mixture of aliphatic hydrocarbons such as soya, which is a mixture of C14 to C20 hydrocarbons, or tallow which is a mixture of C16 to C20 aliphatic hydrocarbons, or tall oil which is a mixture of C14 to C18 aliphatic hydrocarbons. In other embodiments, one in which the A group is NH, the value of x+y is preferably two with x having a preferred value of one. In other embodiments in which the A group is O, the preferred value of x+y is two with the value of x being preferably one. One example of a commercially available amine surfactant is TER 2168 Series available from Champion Chemicals located in Fresno, Tex. Other commercially available examples include Ethomeen T/12 a diethoxylated tallow amine; Ethomeen S/12 a diethoxylated soya amine; Duomeen O a N-oleyl-1,3-diaminopropane, Duomeen T a N-tallow-1,3-diaminopropane, all of which are available from Akzo Nobel.
In other embodiments, the surfactant is a tertiary alkyl amine ethoxylate (a cationic surfactant). Triton RW-100 surfactant (X and Y=10 moles of ethylene oxide) and Triton RW-150 surfactant (X and Y=15 moles of ethylene oxide) are examples of tertiary alkyl amine ethoxylates that may be purchased from Dow Chemical Company.
In other embodiments, the surfactant is a combination of an amphoteric surfactant and an anionic surfactant. The relative amounts of the amphoteric surfactant and the anionic surfactant in the surfactant mixture are from about 30 to about 45% by weight of the surfactant mixture and from about 55 to about 70% by weight of the surfactant mixture, respectively. The amphoteric surfactant may be lauryl amine oxide, a mixture of lauryl amine oxide and myristyl amine oxide (i.e., a lauryl/myristyl amine oxide), cocoamine oxide, lauryl betaine, oleyl betaine, or combinations thereof, with the lauryl/myristyl amine oxide being preferred. The cationic surfactant may be cocoalkyltriethyl ammonium chloride, hexadecyltrimethyl ammonium chloride, or combinations thereof, with a 50/50 mixture by weight of the cocoalkyltriethyl ammonium chloride and the hexadecyltrimethyl ammonium chloride being preferred.
In yet other embodiments, the surfactant is a nonionic surfactant. Such preferred nonionic surfactants include, but are not limited to, alcohol oxylalkylates, alkyl phenol oxylalkylates, nonionic esters such as sorbitan esters and alkoxylates of sorbitan esters. Examples of suitable surfactants include but are not limited to, castor oil alkoxylates, fatty acid alkoxylates, lauryl alcohol alkoxylates, nonylphenol alkoxylates, octylphenol alkoxylates, tridecyl alcohol alkoxylates, such as POE-10 nonylphenol ethoxylate, POE-100 nonylphenol ethoxylate, POE-12 nonylphenol ethoxylate, POE-12 octylphenol ethoxylate, POE-12 tridecyl alcohol ethoxylate, POE-14 nonylphenol ethoxylate, POE-15 nonylphenol ethoxylate, POE-18 tridecyl alcohol ethoxylate, POE-20 nonylphenol ethoxylate, POE-20 oleyl alcohol ethoxylate, POE-20 stearic acid ethoxylate, POE-3 tridecyl alcohol ethoxylate, POE-30 nonylphenol ethoxylate, POE-30 octylphenol ethoxylate, POE-34 nonylphenol ethoxylate, POE-4 nonylphenol ethoxylate, POE-40 castor oil ethoxylate, POE-40 nonylphenol ethoxylate, POE-40 octylphenol ethoxylate, POE-50 nonylphenol ethoxylate, POE-50 tridecyl alcohol ethoxylate, POE-6 nonylphenol ethoxylate, POE-6 tridecyl alcohol ethoxylate, POE-8 nonylphenol ethoxylate, POE-9 octylphenol ethoxylate, mannide monooleate, sorbitan isostearate, sorbitan laurate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monooleate, sorbitan monopalmitate, sorbitan monostearate, sorbitan oleate, sorbitan palmitate, sorbitan sesquioleate, sorbitan stearate, sorbitan trioleate, sorbitan tristearate, POE-20 sorbitan monoisostearate ethoxylate, POE-20 sorbitan monolaurate ethoxylate, POE-20 sorbitan monooleate ethoxylate, POE-20 sorbitan monopalmitate ethoxylate, POE-20 sorbitan monostearate ethoxylate, POE-20 sorbitan trioleate ethoxylate, POE-20 sorbitan tristearate ethoxylate, POE-30 sorbitan tetraoleate ethoxylate, POE-40 sorbitan tetraoleate ethoxylate, POE-6 sorbitan hexastearate ethoxylate, POE-6 sorbitan monstearate ethoxylate, POE-6 sorbitan tetraoleate ethoxylate, and/or POE-60 sorbitan tetrastearate ethoxylate. Preferred nonionic surfactants include alcohol oxyalkyalates such as POE-23 lauryl alcohol and alkyl phenol ethoxylates such as POE (20) nonyl phenyl ether. Other applicable nonionic surfactants are esters such as sorbitan monooleate.
While cationic, amphoteric, and nonionic surfactants are preferred, any suitable emulsifying surfactant can be used. Good surfactants for emulsification typically need to be either ionic to give charge stabilization or have long groups for steric stability in water. This would include other cationic surfactants and even anionic surfactants. Examples include, but are not limited to, hexahydro-1,3,5-tris(2-hydroxyethyl)triazine, alkyl ether phosphate, ammonium lauryl sulfate, ammonium nonylphenol ethoxylate sulfate, branched isopropyl amine dodecylbenzene sulfonate, branched sodium dodecylbenzene sulfonate, dodecylbenzene sulfonic acid, branched dodecylbenzene sulfonic acid, fatty acid sulfonate potassium salt, phosphate esters, POE-1 ammonium lauryl ether sulfate, OE-1 sodium lauryl ether sulfate, POE-10 nonylphenol ethoxylate phosphate ester, POE-12 ammonium lauryl ether sulfate, POE-12 linear phosphate ester, POE-12 sodium lauryl ether sulfate, POE-12 tridecyl alcohol phosphate ester, POE-2 ammonium lauryl ether sulfate, POE-2 sodium lauryl ether sulfate, POE-3 ammonium lauryl ether sulfate, POE-3 disodium alkyl ether sulfosuccinate, POE-3 linear phosphate ester, POE-3 sodium lauryl ether sulfate, POE-3 sodium octylphenol ethoxylate sulfate, POE-3 sodium tridecyl ether sulfate, POE-3 tridecyl alcohol phosphate ester, POE-30 ammonium lauryl ether sulfate, POE-30 sodium lauryl ether sulfate, POE-4 ammonium lauryl ether sulfate, POE-4 ammonium nonylphenol ethoxylate sulfate, POE-4 nonyl phenol ether sulfate, POE-4 nonylphenol ethoxylate phosphate ester, POE-4 sodium lauryl ether sulfate, POE-4 sodium nonylphenol ethoxylate sulfate, POE-4 sodium tridecyl ether sulfate, POE-50 sodium lauryl ether sulfate, POE-6 disodium alkyl ether sulfosuccinate, POE-6 nonylphenol ethoxylate phosphate ester, POE-6 tridecyl alcohol phosphate ester, POE-7 linear phosphate ester, POE-8 nonylphenol ethoxylate phosphate ester, potassium dodecylbenzene sulfonate, sodium 2-ethyl hexyl sulfate, sodium alkyl ether sulfate, sodium alkyl sulfate, sodium alpha olefin sulfonate, sodium decyl sulfate, sodium dodecylbenzene sulfonate, sodium lauryl sulfate, sodium lauryl sulfoacetate, sodium nonylphenol ethoxylate sulfate, and/or sodium octyl sulfate.
The surfactant is preferably present in the consolidating agent emulsion in an amount in the range from about 0.1% to 10% by weight of the composition.
3. Optional Additives
Optionally, the consolidating agent emulsions of the present invention may comprise additional additives such as emulsion stabilizers, emulsion destabilizers, antifreeze agents, and clay stabilizers. For instance, an emulsion stabilizer may be beneficial when stability of the emulsion is desired for a lengthened period of time or at specified temperatures. The emulsion stabilizer may be any acid but preferably organic acid and more preferably acetic acid. If an emulsion stabilizer is utilized, it is preferably present in an amount in the range from about 0.1% to 5% by weight of the consolidating agent emulsion composition. An emulsion destabilizer may be beneficial when stability of the emulsion is not desired. The emulsion destabilizer may be, inter alia, an alcohol, a pH additive, a surfactant or an oil. If an emulsion destabilizer is utilized, it is preferably present in an amount necessary to break the emulsion. Additionally, antifreeze agents may be beneficial to improve the freezing point of the emulsion. One of the ordinary skill in the art with the benefit of this disclosure will recognize that the compatibility of any given additive should be tested to ensure that it does not adversely affect the performance of the consolidating agent emulsion.
B. Methods of Use
The consolidating agent emulsions of the present invention may be used in any suitable well treatment in which it is desirable to control particulate migration and/or modify the stress-activated reactivity of subterranean fracture faces and other surfaces in subterranean formations. These methods can be performed at any time during the life of the well.
One example of a method of the present invention comprises the steps of: providing a consolidating agent emulsion that comprises an aqueous fluid, a surfactant, and a consolidating agent; and coating at least a plurality of particulates with the consolidating agent emulsion to produce a plurality of consolidating agent coated particulates. These consolidating agent coated particulates may then be used downhole, for example, in a fracturing or a gravel packing operation. The term “coated particulate” as used herein means particulates that have been at least partially coated with a process comprising a consolidating agent emulsion of the present invention. The particulates may be coated by any suitable method as recognized by one skilled in the art with the benefit of this disclosure. The term “coated” does not imply any particular degree of coverage of the particulates with a consolidating agent.
In other embodiments, the present invention provides a method comprising providing a treatment fluid that comprises a consolidating agent emulsion that comprises an aqueous fluid, a surfactant, and a consolidating agent; and introducing the treatment fluid into a subterranean formation. The consolidating agent emulsion may then control particulate migration by allowing the consolidating agent to consolidate at least a portion of an unconsolidated subterranean formation.
In other embodiments, the present invention provides a method comprising providing a treatment fluid that comprises at least a plurality of particulates coated with a consolidating agent emulsion that comprises an aqueous fluid, a surfactant, and a consolidating agent; introducing the treatment fluid into a subterranean formation; and allowing the consolidating agent to interact with at least a portion of a mineral surface to modify the stress-activated reactivity of at least a portion of a mineral surface in the subterranean formation.
In some embodiments, the consolidating agent emulsions of the present invention may be used, inter alia, in primary, remedial, or proactive methods. Whether a particular method of this invention is “primary,” “remedial,” or “proactive” is determined relative to the timing of a fracturing treatment or a gravel packing treatment. A primary method of the present invention may involve using the consolidating agent emulsions of the present invention in conjunction with a fracturing fluid or a gravel pack fluid (e.g., as a component of the fracturing fluid or a gravel pack fluid so that the consolidating agent emulsions of the present invention are introduced into the subterranean formation with the fluid). The remedial methods may be used in wells wherein a portion of the well has been fractured and propped. The remedial methods also may be used in a gravel packing situation, for example where there has been a screen problem or failure. The proactive methods may be used in wells that have not yet been fractured or gravel packed. The proactive methods can be performed in conjunction with a fracturing treatment, for example, as a pre-pad to the fracturing treatment or in any diagnostic pumping stage performed before a fracturing, gravel packing, or acidizing procedure.
One of ordinary skill in the art will recognize that the present invention may be useful to stabilize other types of particulates, such as the coatings (also referred to as “grapeskin”) left over from some encapsulated materials.
Below are some additional examples of some of the primary, remedial, and proactive methods of the present invention.
1. Primary Methods
In some embodiments, the consolidating agent emulsions of the present invention may be used in a primary method with a well treatment fluid, such as a fracturing fluid or a gravel pack fluid. One example of such a method comprises: providing a fracturing fluid that comprises a consolidating agent emulsion comprising an aqueous fluid, a surfactant, and a consolidating agent; placing the fracturing fluid into a subterranean formation at a pressure sufficient to create or enhance a fracture therein; and allowing the consolidating agent to at least partially consolidate particulates within a portion of the subterranean formation.
The fracturing fluids in these primary embodiments may comprise those things usually found in fracturing fluids including, but not limited to, an aqueous base fluid, proppant particulates, gelling agents, surfactants, breakers, buffers, a gas phase (if the fracturing fluid is foamed or commingled), coupling agents, and the like.
One example of a primary gravel pack method of the present invention comprises: providing a gravel pack fluid that comprises gravel and a consolidating agent emulsion composition, the consolidating agent emulsion composition comprising an aqueous fluid, a surfactant, and a consolidating agent; contacting the portion of the subterranean formation with the gravel pack fluid so as to place a gravel pack in or near a portion of the subterranean formation; and allowing the consolidating agent to stabilize particulates within the subterranean formation. The gravel pack fluids used in these embodiments may be any suitable gravel pack fluid, and it may comprise those things usually found in gravel pack fluids including, but not limited to, an aqueous base fluid, gravel particulates, gelling agents, surfactants, breakers, buffers, a gas phase (if the fluid is foamed or commingled), and the like.
2. Remedial Measures
In some remedial embodiments of the present invention, after a fracturing treatment or a gravel pack treatment has been performed, the consolidating agent emulsions of the present invention may be introduced into an unconsolidated zone of a subterranean formation to stabilize particulates within the zone. The consolidating agent emulsions may disperse any loose fines within a proppant pack in a fracture, move any fines away from the fracture (or near well bore), stabilize gravel particulates around a screen, stabilize a screen failure, and lock the fines in the formation without causing damage to the permeability of the formation.
3. The Proactive Methods
The proactive methods of the present invention are most suited for wells that have not been fractured or gravel packed yet. These methods can be used as a pre-treatment before a fracturing treatment or at the early stage of a fracturing treatment (including diagnostic pumping) as a pre-pad treatment.
In some embodiments, the proactive methods of the present invention comprise placing the consolidating agent emulsions before or as part of a pre-pad of a fracturing treatment into a subterranean formation. The second step involves fracturing a portion of the subterranean formation. This fracturing step may include the introduction of a plurality of particulates into the formation. At least a portion of the particulates may be coated with a consolidating agent. In some embodiments, the coated particulates may be introduced into the fluid at the end of the fracturing treatment. The third step involves introducing particulates during the fracturing treatment into the fractures created in the fracturing treatment. The particulates may form proppant packs in the fractures. In certain embodiments, all three steps may be performed with a single fluid.
4. Introducing Coated Particulates
In some embodiments, the consolidating agent emulsions of the present invention may be coated on particulates to be used in a fracturing or gravel packing process like those described above. The resultant coated particulates may be introduced as part of a fracturing or gravel packing process, at any point during one of the methods described above. Preferably, the coated particulate is introduced towards the end of a fracturing or gravel packing treatment so that the maximum economic benefit can be obtained.
In accordance with the methods and compositions of the present invention, all or part of the particulate transported into the fractures is coated (preferably on-the-fly) with a consolidating agent using the consolidating agent emulsions of the present invention and may then be suspended in a fracturing fluid or used as part of a gravel packing process. The consolidating agent emulsions are used to coat the consolidating agent on dry particulates while the particulates are conveyed in a conveying and/or mixing device. The amount of consolidating agent coated on the particulates is in the range from about 0.1% to about 20% by weight of the particulate, with about 1-5% being preferred.
The term “on-the-fly” is used herein to mean that a flowing stream is continuously introduced into another flowing stream so that the streams are combined and mixed while continuing to flow as a single stream. The coating of the dry particulates with the consolidating agent emulsions and any mixing of the consolidating agent coated particulates with a fracturing fluid or treatment fluid are all preferably accomplished on-the-fly. However, as is well understood by those skilled in the art, such mixing can also be accomplished by batch mixing or partial batch mixing.
A wide variety of particulate materials may be used in accordance with the present invention, including, but not limited to, sand, bauxite, ceramic materials, glass materials, resin precoated proppant (e.g., commercially available from Borden Chemicals and Santrol, for example, both from Houston, Tex.), polymer materials, “TEFLON™” (tetrafluoroethylene) materials, nut shells, ground or crushed nut shells, seed shells, ground or crushed seed shells, fruit pit pieces, ground or crushed fruit pits, processed wood, composite particulates prepared from a binder with filler particulate including silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly ash, hollow glass microspheres, and solid glass; or mixtures thereof. The particulate material used may have a particle size in the range of from about 2 to about 400 mesh, U.S. Sieve Series. Preferably, the particulate material is graded sand having a particle size in the range of from about 10 to about 70 mesh, U.S. Sieve Series. Preferred sand particle size distribution ranges are one or more of 10-20 mesh, 20-40 mesh, 40-60 mesh or 50-70 mesh, depending on the particle size and distribution of the formation particulates to be screened out by the particulate materials.
To facilitate a better understanding of the present invention, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the entire scope of the invention.
Diagenesis tests were performed using 3-in. diameter radial API conductivity cells fitted with Ohio sandstone core wafers on the top and bottom of the proppant pack. Alumina-based proppant loading of 2 lb/ft2 was used for the proppant pack, with 2% KCl as the fluid medium. Sample proppant pack No. 1 contained untreated proppant and Sample proppant pack No. 2 contained proppant that was coated using the consolidating agent emulsions of the present invention.
After preparation, each sample was subjected to a stress load of 10,000 psi at 250° F. for 126 hours in static conditions. The API conductivity cell was then disassembled, and the Ohio sandstone wafers were examined to determine proppant particulate embedment by optical microscopy. For each sample, the proppant layer next to the Ohio sandstone wafer and the center of the proppant pack were examined by Environmental Scanning Electron Microscope.
Electron dispersive X-ray (EDX) was also used to determine the silica-to-aluminum ratio in various areas of Sample proppant pack No. 1. The silica-to-aluminum ratio observed for the proppant was 0.9, as is typical for ceramic proppant, while that for the Ohio sandstone was 8.4. The porosity filling precipitate was found to be 4.9, or an intermediate concentration of these metals. The silica-to-aluminum ratio was not measured in Sample proppant pack No. 2 because the porosity filling precipitate was not found in the pack.
Thus, by treating the proppant pack with the consolidating agent emulsions of the present invention, diagenesis was reduced and the porosity filling precipitate was eliminated from the pack.
Conductivity tests were performed by preparing 5-lb/ft2 proppant packs of 20/40-mesh ceramic proppant. Sample proppant pack No. 3 and Sample proppant pack No. 4 were each separately placed between two unconsolidated silica wafers, which were used to simulate unconsolidated formation faces of a soft formation. Each sample proppant pack and the two unconsolidated silica wafers were then placed between two Ohio sandstone core wafers and placed in a linear API conductivity cell.
The two cells were then brought to an initial stress of 2,000 psi and 180° F. Sample proppant pack No. 3 was then treated with only 3% KCl and Sample proppant pack No. 4 was treated with the consolidating agent emulsions of the present invention. Both treatments were performed by injecting the proppant pack with 3 pore volumes of the treatment fluid. Flow was then initiated through each Sample proppant pack in the conventional linear direction to determine the initial conductivity of each of the Sample proppant packs at 2,000 psi closure stress. After stable flow was achieved, flow at a rate of 2 mL/min was initiated through the wafers to simulate production from the formation into the fracture. The effluent fluid was then captured to examine for fines production.
Sample proppant pack No. 3 failed with the continuous flow from the silica wafers into the proppant pack. This failure resulted in the fines exiting the test cell, thereby causing the overall width to collapse. The collapse was caused by the flow removing the fines that make up the wafer and transporting them through the proppant pack and out of the cell. After the failure of the proppant pack, all flow was stopped for this test cell. Differential pressure for the conductivity measurement increased beyond the capacity of the sensor because of the fines invasion into the pack. Therefore, no subsequent values were obtained for Sample proppant pack No. 3.
Sample proppant pack No. 4 continued to allow inflow through the silica wafers without failure or collapse of the overall width. After reaching stable conductivity measurements at 2,000 psi closure, the stress load was increased to 4,000 psi closure. Again, after reaching stable conductivity measurements, the stress load was decreased back to 2,000 psi closure. This stress cycle was repeated several times with a doubling in inflow rate with each cycle to try to destabilize the pack.
Conductivity results for Sample proppant pack No. 3 and Sample proppant pack No. 4 are shown in Table 1 below.
Thus, Example 2 demonstrates, inter alia, that the consolidating agent emulsions of the present invention may effective control or mitigate the invasion of formation fines into the proppant and may allow the proppant pack to maintain conductivity.
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood as referring to the power set (the set of all subsets) of the respective range of values, and set forth every range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
Number | Name | Date | Kind |
---|---|---|---|
2238671 | Woodhouse | Apr 1941 | A |
2604947 | Martin | Jul 1952 | A |
2611750 | White et al. | Sep 1952 | A |
2703316 | Schneider | Mar 1955 | A |
2869642 | McKay et al. | Jan 1959 | A |
3047067 | Williams et al. | Jul 1962 | A |
3052298 | Malott | Sep 1962 | A |
3070165 | Stratton | Dec 1962 | A |
3123138 | Robichaux | Mar 1964 | A |
3173484 | Huitt et al. | Mar 1965 | A |
3176768 | Brandt et al. | Apr 1965 | A |
3195635 | Fast | Jul 1965 | A |
3199590 | Young | Aug 1965 | A |
3272650 | MacVittie | Sep 1966 | A |
3297086 | Spain | Jan 1967 | A |
3302719 | Fischer | Feb 1967 | A |
3308885 | Sandiford | Mar 1967 | A |
3308886 | Evans | Mar 1967 | A |
3310111 | Pavlich et al. | Mar 1967 | A |
3316965 | Watanabe | May 1967 | A |
3329204 | Brieger | Jul 1967 | A |
3336980 | Rike | Aug 1967 | A |
3364995 | Atkins et al. | Jan 1968 | A |
3366178 | Malone et al. | Jan 1968 | A |
3371712 | Adams | Mar 1968 | A |
3375872 | McLaughlin et al. | Apr 1968 | A |
3378074 | Kiel | Apr 1968 | A |
3404735 | Young et al. | Oct 1968 | A |
3415320 | Young | Dec 1968 | A |
3455390 | Gallus | Jul 1969 | A |
3478824 | Hess et al. | Nov 1969 | A |
3481403 | Gidley et al. | Dec 1969 | A |
3489222 | Millhone et al. | Jan 1970 | A |
3492147 | Young et al. | Jan 1970 | A |
3525398 | Fisher | Aug 1970 | A |
3565176 | Clifford | Feb 1971 | A |
3592266 | Tinsley | Jul 1971 | A |
3659651 | Graham | May 1972 | A |
3681287 | Brown et al. | Aug 1972 | A |
3708013 | Dismukes | Jan 1973 | A |
3709298 | Pramann | Jan 1973 | A |
3709641 | Sarem | Jan 1973 | A |
3741308 | Veley | Jun 1973 | A |
3743019 | Totty | Jul 1973 | A |
3754598 | Holloway, Jr. | Aug 1973 | A |
3765804 | Brandon | Oct 1973 | A |
3768564 | Knox et al. | Oct 1973 | A |
3769070 | Schilt | Oct 1973 | A |
3784585 | Schmitt et al. | Jan 1974 | A |
3819525 | Hattenbrun | Jun 1974 | A |
3826310 | Karnes | Jul 1974 | A |
3828854 | Templeton et al. | Aug 1974 | A |
3842911 | Knox et al. | Oct 1974 | A |
3850247 | Tinsley | Nov 1974 | A |
3854533 | Gurley et al. | Dec 1974 | A |
3857444 | Copeland | Dec 1974 | A |
3861467 | Harnsberger | Jan 1975 | A |
3863709 | Fitch | Feb 1975 | A |
3868998 | Lybarger et al. | Mar 1975 | A |
3878893 | Copeland | Apr 1975 | A |
3888311 | Cooke, Jr. | Jun 1975 | A |
3912692 | Casey et al. | Oct 1975 | A |
3933204 | Knapp | Jan 1976 | A |
3933205 | Kiel | Jan 1976 | A |
3948672 | Harnsberger | Apr 1976 | A |
3955993 | Curtice et al. | May 1976 | A |
3960736 | Free et al. | Jun 1976 | A |
3976135 | Anderson | Aug 1976 | A |
3977472 | Graham et al. | Aug 1976 | A |
4000781 | Knapp | Jan 1977 | A |
4008763 | Lowe, Jr. | Feb 1977 | A |
4015995 | Hess | Apr 1977 | A |
4018285 | Watkins et al. | Apr 1977 | A |
4029148 | Emery | Jun 1977 | A |
4031958 | Sandiford et al. | Jun 1977 | A |
4042032 | Anderson et al. | Aug 1977 | A |
4060988 | Arnold | Dec 1977 | A |
4068718 | Cooke, Jr. et al. | Jan 1978 | A |
4070865 | McLaughlin | Jan 1978 | A |
4074760 | Copeland et al. | Feb 1978 | A |
4085801 | Sifferman et al. | Apr 1978 | A |
4085802 | Sifferman et al. | Apr 1978 | A |
4089437 | Chutter et al. | May 1978 | A |
4127173 | Watkins et al. | Nov 1978 | A |
4169798 | DeMartino | Oct 1979 | A |
4172066 | Zweigle et al. | Oct 1979 | A |
4220566 | Constien et al. | Sep 1980 | A |
4245702 | Haafkens et al. | Jan 1981 | A |
4247430 | Constien | Jan 1981 | A |
4259205 | Murphey | Mar 1981 | A |
4273187 | Satter et al. | Jun 1981 | A |
4291766 | Davies et al. | Sep 1981 | A |
4305463 | Zakiewicz | Dec 1981 | A |
4336842 | Graham et al. | Jun 1982 | A |
4352674 | Fery | Oct 1982 | A |
4353806 | Canter et al. | Oct 1982 | A |
4387769 | Erbstoesser et al. | Jun 1983 | A |
4392988 | Dobson et al. | Jul 1983 | A |
4399866 | Dearth | Aug 1983 | A |
4415805 | Fertl et al. | Nov 1983 | A |
4428427 | Friedman | Jan 1984 | A |
4439489 | Johnson et al. | Mar 1984 | A |
4441556 | Powers et al. | Apr 1984 | A |
4443347 | Underdown et al. | Apr 1984 | A |
4460052 | Gockel | Jul 1984 | A |
4470915 | Conway | Sep 1984 | A |
4493875 | Beck et al. | Jan 1985 | A |
4494605 | Wiechel et al. | Jan 1985 | A |
4498995 | Gockel et al. | Feb 1985 | A |
4501328 | Nichols | Feb 1985 | A |
4526695 | Erbstoesser et al. | Jul 1985 | A |
4527627 | Graham et al. | Jul 1985 | A |
4541489 | Wu | Sep 1985 | A |
4546012 | Brooks | Oct 1985 | A |
4553596 | Graham et al. | Nov 1985 | A |
4564459 | Underdown et al. | Jan 1986 | A |
4572803 | Yamazoe et al. | Feb 1986 | A |
4585064 | Graham et al. | Apr 1986 | A |
4649998 | Friedman | Mar 1987 | A |
4662449 | Friedman | May 1987 | A |
4664819 | Glaze et al. | May 1987 | A |
4665988 | Murphey et al. | May 1987 | A |
4669543 | Young | Jun 1987 | A |
4670501 | Dymond et al. | Jun 1987 | A |
4675140 | Sparks et al. | Jun 1987 | A |
4681165 | Bannister | Jul 1987 | A |
4683954 | Walker et al. | Aug 1987 | A |
4694905 | Armbruster | Sep 1987 | A |
4715967 | Bellis | Dec 1987 | A |
4716964 | Erbstoesser et al. | Jan 1988 | A |
4733729 | Copeland | Mar 1988 | A |
4739832 | Jennings, Jr. et al. | Apr 1988 | A |
4772646 | Harms et al. | Sep 1988 | A |
4777200 | Dymond et al. | Oct 1988 | A |
4785884 | Armbruster | Nov 1988 | A |
4787453 | Hewgill et al. | Nov 1988 | A |
4789105 | Hosokawa et al. | Dec 1988 | A |
4796701 | Hudson et al. | Jan 1989 | A |
4797262 | Dewitz | Jan 1989 | A |
4800960 | Friedman et al. | Jan 1989 | A |
4809783 | Hollenbeck et al. | Mar 1989 | A |
4817721 | Pober | Apr 1989 | A |
4829100 | Murphey et al. | May 1989 | A |
4838352 | Oberste-Padtberg et al. | Jun 1989 | A |
4842070 | Sharp | Jun 1989 | A |
4842072 | Friedman et al. | Jun 1989 | A |
4846118 | Slattery et al. | Jul 1989 | A |
4848467 | Cantu et al. | Jul 1989 | A |
4848470 | Korpics | Jul 1989 | A |
4850430 | Copeland et al. | Jul 1989 | A |
4875525 | Mana | Oct 1989 | A |
4886354 | Welch et al. | Dec 1989 | A |
4888240 | Graham et al. | Dec 1989 | A |
4892147 | Jennings, Jr. et al. | Jan 1990 | A |
4895207 | Friedman et al. | Jan 1990 | A |
4898750 | Friedman et al. | Feb 1990 | A |
4903770 | Friedman et al. | Feb 1990 | A |
4921576 | Hurd | May 1990 | A |
4934456 | Moradi-Araghi | Jun 1990 | A |
4936385 | Weaver et al. | Jun 1990 | A |
4942186 | Murphey et al. | Jul 1990 | A |
4957165 | Cantu et al. | Sep 1990 | A |
4959432 | Fan et al. | Sep 1990 | A |
4961466 | Himes et al. | Oct 1990 | A |
4969522 | Whitehurst et al. | Nov 1990 | A |
4969523 | Martin et al. | Nov 1990 | A |
4984635 | Cullick et al. | Jan 1991 | A |
4986353 | Clark et al. | Jan 1991 | A |
4986354 | Cantu et al. | Jan 1991 | A |
4986355 | Casad et al. | Jan 1991 | A |
5030603 | Rumpf et al. | Jul 1991 | A |
5049743 | Taylor, III et al. | Sep 1991 | A |
5056597 | Stowe, III et al. | Oct 1991 | A |
5082056 | Tackett, Jr. et al. | Jan 1992 | A |
5095987 | Weaver et al. | Mar 1992 | A |
5105886 | Strubhar et al. | Apr 1992 | A |
5107928 | Hilterhaus | Apr 1992 | A |
5128390 | Murphey et al. | Jul 1992 | A |
5135051 | Facteau et al. | Aug 1992 | A |
5142023 | Gruber et al. | Aug 1992 | A |
5165438 | Facteau et al. | Nov 1992 | A |
5173527 | Calve et al. | Dec 1992 | A |
5178218 | Dees | Jan 1993 | A |
5182051 | Bandy et al. | Jan 1993 | A |
5199491 | Kutta et al. | Apr 1993 | A |
5199492 | Surles et al. | Apr 1993 | A |
5211234 | Floyd | May 1993 | A |
5216050 | Sinclair | Jun 1993 | A |
5218038 | Johnson et al. | Jun 1993 | A |
5232955 | Csabai et al. | Aug 1993 | A |
5232961 | Murphey et al. | Aug 1993 | A |
5238068 | Fredrickson et al. | Aug 1993 | A |
5244362 | Conally et al. | Sep 1993 | A |
5247059 | Gruber et al. | Sep 1993 | A |
5249627 | Harms et al. | Oct 1993 | A |
5249628 | Surjaatmadia | Oct 1993 | A |
5256729 | Kutta et al. | Oct 1993 | A |
5265678 | Grundmann | Nov 1993 | A |
5273115 | Spafford | Dec 1993 | A |
5278203 | Harms | Jan 1994 | A |
5285849 | Surles et al. | Feb 1994 | A |
5293939 | Surles et al. | Mar 1994 | A |
5295542 | Cole et al. | Mar 1994 | A |
5320171 | Laramay | Jun 1994 | A |
5321062 | Landrum et al. | Jun 1994 | A |
5325923 | Surjaatmadja et al. | Jul 1994 | A |
5330005 | Card et al. | Jul 1994 | A |
5332037 | Schmidt et al. | Jul 1994 | A |
5335726 | Rodrigues | Aug 1994 | A |
5351754 | Hardin et al. | Oct 1994 | A |
5358051 | Rodrigues | Oct 1994 | A |
5359026 | Gruber | Oct 1994 | A |
5360068 | Sprunt et al. | Nov 1994 | A |
5361856 | Surjaatmadja et al. | Nov 1994 | A |
5363916 | Himes et al. | Nov 1994 | A |
5373901 | Norman et al. | Dec 1994 | A |
5377756 | Northrop et al. | Jan 1995 | A |
5377759 | Surles | Jan 1995 | A |
5381864 | Nguyen et al. | Jan 1995 | A |
5386874 | Laramay et al. | Feb 1995 | A |
5388648 | Jordan, Jr. | Feb 1995 | A |
5390741 | Payton et al. | Feb 1995 | A |
5393810 | Harris et al. | Feb 1995 | A |
5396957 | Surjaatmadja et al. | Mar 1995 | A |
5402846 | Jennings, Jr. et al. | Apr 1995 | A |
5403822 | Mueller et al. | Apr 1995 | A |
5420174 | Dewprashad | May 1995 | A |
5422183 | Sinclair et al. | Jun 1995 | A |
5423381 | Surles et al. | Jun 1995 | A |
5439055 | Card et al. | Aug 1995 | A |
5460226 | Lawton et al. | Oct 1995 | A |
5464060 | Hale et al. | Nov 1995 | A |
5475080 | Gruber et al. | Dec 1995 | A |
5484881 | Gruber et al. | Jan 1996 | A |
5492177 | Yeh et al. | Feb 1996 | A |
5492178 | Nguyen et al. | Feb 1996 | A |
5494103 | Surjaatmadja et al. | Feb 1996 | A |
5494178 | Maharg | Feb 1996 | A |
5497830 | Boles et al. | Mar 1996 | A |
5498280 | Fistner et al. | Mar 1996 | A |
5499678 | Surjaatmadja et al. | Mar 1996 | A |
5501275 | Card et al. | Mar 1996 | A |
5505787 | Yamaguchi | Apr 1996 | A |
5512071 | Yam et al. | Apr 1996 | A |
5520250 | Harry et al. | May 1996 | A |
5522460 | Shu | Jun 1996 | A |
5529123 | Carpenter et al. | Jun 1996 | A |
5531274 | Bienvenu, Jr. | Jul 1996 | A |
5536807 | Gruber et al. | Jul 1996 | A |
5545824 | Stengel et al. | Aug 1996 | A |
5547023 | McDaniel et al. | Aug 1996 | A |
5551513 | Surles et al. | Sep 1996 | A |
5551514 | Nelson et al. | Sep 1996 | A |
5582249 | Caveny et al. | Dec 1996 | A |
5582250 | Constien | Dec 1996 | A |
5588488 | Vijn et al. | Dec 1996 | A |
5591700 | Harris et al. | Jan 1997 | A |
5594095 | Gruber et al. | Jan 1997 | A |
5595245 | Scott, III | Jan 1997 | A |
5597784 | Sinclair et al. | Jan 1997 | A |
5604184 | Ellis et al. | Feb 1997 | A |
5604186 | Hunt et al. | Feb 1997 | A |
5609207 | Dewprashad et al. | Mar 1997 | A |
5620049 | Gipson et al. | Apr 1997 | A |
5639806 | Johnson et al. | Jun 1997 | A |
5663123 | Goodhue, Jr. et al. | Sep 1997 | A |
5670473 | Scepanski | Sep 1997 | A |
5692566 | Surles | Dec 1997 | A |
5697440 | Weaver et al. | Dec 1997 | A |
5697448 | Johnson | Dec 1997 | A |
5698322 | Tsai et al. | Dec 1997 | A |
5701956 | Hardy et al. | Dec 1997 | A |
5712314 | Surles et al. | Jan 1998 | A |
5732364 | Kalb et al. | Mar 1998 | A |
5738136 | Rosenberg | Apr 1998 | A |
5765642 | Surjaatmadja | Jun 1998 | A |
5775425 | Weaver et al. | Jul 1998 | A |
5782300 | James et al. | Jul 1998 | A |
5783822 | Buchanan et al. | Jul 1998 | A |
5787986 | Weaver et al. | Aug 1998 | A |
5791415 | Nguyen et al. | Aug 1998 | A |
5799734 | Norman et al. | Sep 1998 | A |
5806593 | Surles | Sep 1998 | A |
5830987 | Smith | Nov 1998 | A |
5833000 | Weaver et al. | Nov 1998 | A |
5833361 | Funk | Nov 1998 | A |
5836391 | Jonasson et al. | Nov 1998 | A |
5836392 | Urlwin-Smith | Nov 1998 | A |
5836393 | Johnson | Nov 1998 | A |
5837656 | Sinclair et al. | Nov 1998 | A |
5837785 | Kinsho et al. | Nov 1998 | A |
5839510 | Weaver et al. | Nov 1998 | A |
5840784 | Funkhouser et al. | Nov 1998 | A |
5849401 | El-Afandi et al. | Dec 1998 | A |
5849590 | Anderson, II et al. | Dec 1998 | A |
5853048 | Weaver et al. | Dec 1998 | A |
5864003 | Qureshi et al. | Jan 1999 | A |
5865936 | Edelman et al. | Feb 1999 | A |
5871049 | Weaver et al. | Feb 1999 | A |
5873413 | Chatterji et al. | Feb 1999 | A |
5874490 | Arora et al. | Feb 1999 | A |
5875844 | Chatterji et al. | Mar 1999 | A |
5875845 | Chatterji et al. | Mar 1999 | A |
5875846 | Chatterji et al. | Mar 1999 | A |
5893383 | Fracteau | Apr 1999 | A |
5893416 | Read | Apr 1999 | A |
5901789 | Donnelly et al. | May 1999 | A |
5908073 | Nguyen et al. | Jun 1999 | A |
5911282 | Onan et al. | Jun 1999 | A |
5913364 | Sweatman | Jun 1999 | A |
5916933 | Johnson et al. | Jun 1999 | A |
5921317 | Dewprashad et al. | Jul 1999 | A |
5924488 | Nguyen et al. | Jul 1999 | A |
5929437 | Elliott et al. | Jul 1999 | A |
5944105 | Nguyen | Aug 1999 | A |
5944106 | Dalrymple et al. | Aug 1999 | A |
5945387 | Chatterji et al. | Aug 1999 | A |
5948734 | Sinclair et al. | Sep 1999 | A |
5957204 | Chatterji et al. | Sep 1999 | A |
5960784 | Ryan | Oct 1999 | A |
5960877 | Funkhouser et al. | Oct 1999 | A |
5960878 | Nguyen et al. | Oct 1999 | A |
5960880 | Nguyen et al. | Oct 1999 | A |
5964291 | Bourne et al. | Oct 1999 | A |
5969006 | Onan et al. | Oct 1999 | A |
5969523 | Martin et al. | Oct 1999 | A |
5969823 | Wurz et al. | Oct 1999 | A |
5977283 | Rossitto | Nov 1999 | A |
5994785 | Higuchi et al. | Nov 1999 | A |
RE36466 | Nelson et al. | Dec 1999 | E |
6003600 | Nguyen et al. | Dec 1999 | A |
6004400 | Bishop et al. | Dec 1999 | A |
6006835 | Onan et al. | Dec 1999 | A |
6006836 | Chatterji et al. | Dec 1999 | A |
6012524 | Chatterji et al. | Jan 2000 | A |
6016870 | Dewprashad et al. | Jan 2000 | A |
6024170 | McCabe et al. | Feb 2000 | A |
6028113 | Scepanski | Feb 2000 | A |
6028534 | Ciglenec et al. | Feb 2000 | A |
6035936 | Whalen | Mar 2000 | A |
6040398 | Kinsho et al. | Mar 2000 | A |
6047772 | Weaver et al. | Apr 2000 | A |
6059034 | Rickards et al. | May 2000 | A |
6059035 | Chatterji et al. | May 2000 | A |
6059036 | Chatterji et al. | May 2000 | A |
6063738 | Chatterji et al. | May 2000 | A |
6068055 | Chatterji et al. | May 2000 | A |
6069117 | Onan et al. | May 2000 | A |
6070667 | Gano | Jun 2000 | A |
6074739 | Katagiri | Jun 2000 | A |
6079492 | Hoogteijling et al. | Jun 2000 | A |
6098711 | Chatterji et al. | Aug 2000 | A |
6114410 | Betzold | Sep 2000 | A |
6123871 | Carroll | Sep 2000 | A |
6123965 | Jacob et al. | Sep 2000 | A |
6124246 | Heathman et al. | Sep 2000 | A |
6130286 | Thomas et al. | Oct 2000 | A |
6131661 | Conner et al. | Oct 2000 | A |
6135987 | Tsai et al. | Oct 2000 | A |
6140446 | Fujiki et al. | Oct 2000 | A |
6143698 | Murphey et al. | Nov 2000 | A |
6148911 | Gipson et al. | Nov 2000 | A |
6152234 | Newhouse et al. | Nov 2000 | A |
6162766 | Muir et al. | Dec 2000 | A |
6165947 | Chang et al. | Dec 2000 | A |
6167967 | Sweatman | Jan 2001 | B1 |
6169058 | Le et al. | Jan 2001 | B1 |
6172011 | Card et al. | Jan 2001 | B1 |
6172077 | Curtis et al. | Jan 2001 | B1 |
6176315 | Reddy et al. | Jan 2001 | B1 |
6177484 | Surles | Jan 2001 | B1 |
6184311 | O'Keeffe et al. | Feb 2001 | B1 |
6186228 | Wegener et al. | Feb 2001 | B1 |
6187834 | Thayer et al. | Feb 2001 | B1 |
6187839 | Eoff et al. | Feb 2001 | B1 |
6189615 | Sydansk | Feb 2001 | B1 |
6192985 | Hinkel et al. | Feb 2001 | B1 |
6192986 | Urlwin-Smith | Feb 2001 | B1 |
6196317 | Hardy | Mar 2001 | B1 |
6202751 | Chatterji et al. | Mar 2001 | B1 |
6209643 | Nguyen et al. | Apr 2001 | B1 |
6209644 | Brunet | Apr 2001 | B1 |
6209646 | Reddy et al. | Apr 2001 | B1 |
6210471 | Craig | Apr 2001 | B1 |
6214773 | Harris et al. | Apr 2001 | B1 |
6231664 | Chatterji et al. | May 2001 | B1 |
6234251 | Chatterji et al. | May 2001 | B1 |
6238597 | Yim et al. | May 2001 | B1 |
6241019 | Davidson et al. | Jun 2001 | B1 |
6242390 | Mitchell et al. | Jun 2001 | B1 |
6244344 | Chatterji et al. | Jun 2001 | B1 |
6257335 | Nguyen et al. | Jul 2001 | B1 |
6258757 | Sweatman et al. | Jul 2001 | B1 |
6260622 | Blok et al. | Jul 2001 | B1 |
6271181 | Chatterji et al. | Aug 2001 | B1 |
6274650 | Cui | Aug 2001 | B1 |
6279652 | Chatterji et al. | Aug 2001 | B1 |
6279656 | Sinclair et al. | Aug 2001 | B1 |
6283214 | Guinot et al. | Sep 2001 | B1 |
6302207 | Nguyen et al. | Oct 2001 | B1 |
6306998 | Kimura et al. | Oct 2001 | B1 |
6310008 | Rietjens | Oct 2001 | B1 |
6311773 | Todd et al. | Nov 2001 | B1 |
6315040 | Donnelly | Nov 2001 | B1 |
6321841 | Eoff et al. | Nov 2001 | B1 |
6323307 | Bigg et al. | Nov 2001 | B1 |
6326458 | Gruber et al. | Dec 2001 | B1 |
6328105 | Betzold | Dec 2001 | B1 |
6328106 | Griffith et al. | Dec 2001 | B1 |
6330916 | Rickards et al. | Dec 2001 | B1 |
6330917 | Chatterji et al. | Dec 2001 | B2 |
6342467 | Chang et al. | Jan 2002 | B1 |
6350309 | Chatterji et al. | Feb 2002 | B2 |
6357527 | Norman et al. | Mar 2002 | B1 |
6364018 | Brannon et al. | Apr 2002 | B1 |
6364945 | Chatterji et al. | Apr 2002 | B1 |
6367165 | Huttlin | Apr 2002 | B1 |
6367549 | Chatterji et al. | Apr 2002 | B1 |
6372678 | Youngman et al. | Apr 2002 | B1 |
6376571 | Chawla et al. | Apr 2002 | B1 |
6387986 | Moradi-Araghi et al. | May 2002 | B1 |
6390195 | Nguyen et al. | May 2002 | B1 |
6394181 | Schnatzmeyer et al. | May 2002 | B2 |
6401817 | Griffith et al. | Jun 2002 | B1 |
6405796 | Meyer et al. | Jun 2002 | B1 |
6405797 | Davidson et al. | Jun 2002 | B2 |
6406789 | McDaniel et al. | Jun 2002 | B1 |
6408943 | Schultz et al. | Jun 2002 | B1 |
6415509 | Echols et al. | Jul 2002 | B1 |
6422183 | Kato | Jul 2002 | B1 |
6422314 | Todd et al. | Jul 2002 | B1 |
6439309 | Matherly et al. | Aug 2002 | B1 |
6439310 | Scott, III et al. | Aug 2002 | B1 |
6440255 | Kohlhammer et al. | Aug 2002 | B1 |
6446727 | Zemlak et al. | Sep 2002 | B1 |
6448206 | Griffith et al. | Sep 2002 | B1 |
6450260 | James et al. | Sep 2002 | B1 |
6454003 | Chang et al. | Sep 2002 | B1 |
6457518 | Castano-Mears et al. | Oct 2002 | B1 |
6458885 | Stengel et al. | Oct 2002 | B1 |
6478092 | Voll et al. | Nov 2002 | B2 |
6485947 | Rajgarhia et al. | Nov 2002 | B1 |
6488091 | Weaver et al. | Dec 2002 | B1 |
6488763 | Brothers et al. | Dec 2002 | B2 |
6494263 | Todd | Dec 2002 | B2 |
6503870 | Griffith et al. | Jan 2003 | B2 |
6508305 | Brannon et al. | Jan 2003 | B1 |
6510896 | Bode et al. | Jan 2003 | B2 |
6520255 | Tolman et al. | Feb 2003 | B2 |
6527051 | Reddy et al. | Mar 2003 | B1 |
6528157 | Hussain et al. | Mar 2003 | B1 |
6531427 | Shuchart et al. | Mar 2003 | B1 |
6534449 | Gilmour et al. | Mar 2003 | B1 |
6536939 | Blue | Mar 2003 | B1 |
6538576 | Schultz et al. | Mar 2003 | B1 |
6543545 | Chatterji et al. | Apr 2003 | B1 |
6550959 | Huber et al. | Apr 2003 | B2 |
6552333 | Storm et al. | Apr 2003 | B1 |
6554071 | Crook et al. | Apr 2003 | B1 |
6555507 | Chatterji et al. | Apr 2003 | B2 |
6569814 | Brady et al. | May 2003 | B1 |
6582819 | McDaniel et al. | Jun 2003 | B2 |
6588926 | Huber et al. | Jul 2003 | B2 |
6588928 | Huber et al. | Jul 2003 | B2 |
6593402 | Chatterji et al. | Jul 2003 | B2 |
6599863 | Palmer et al. | Jul 2003 | B1 |
6608162 | Chiu et al. | Aug 2003 | B1 |
6609578 | Patel et al. | Aug 2003 | B2 |
6616320 | Huber et al. | Sep 2003 | B2 |
6620857 | Valet | Sep 2003 | B2 |
6626241 | Nguyen | Sep 2003 | B2 |
6632527 | McDaniel et al. | Oct 2003 | B1 |
6632778 | Ayoub et al. | Oct 2003 | B1 |
6632892 | Rubinsztajn et al. | Oct 2003 | B2 |
6642309 | Komitsu et al. | Nov 2003 | B2 |
6648501 | Huber et al. | Nov 2003 | B2 |
6659179 | Nguyen | Dec 2003 | B2 |
6664343 | Narisawa et al. | Dec 2003 | B2 |
6667279 | Hessert et al. | Dec 2003 | B1 |
6668926 | Nguyen et al. | Dec 2003 | B2 |
6669771 | Tokiwa et al. | Dec 2003 | B2 |
6677426 | Noro et al. | Jan 2004 | B2 |
6681856 | Chatterji et al. | Jan 2004 | B1 |
6686328 | Binder | Feb 2004 | B1 |
6705400 | Nguyen et al. | Mar 2004 | B1 |
6705440 | Nguyen et al. | Mar 2004 | B2 |
6710019 | Sawdon et al. | Mar 2004 | B1 |
6713170 | Kaneko et al. | Mar 2004 | B1 |
6725926 | Nguyen et al. | Apr 2004 | B2 |
6725930 | Boney et al. | Apr 2004 | B2 |
6725931 | Nguyen et al. | Apr 2004 | B2 |
6729404 | Nguyen et al. | May 2004 | B2 |
6729405 | DiLullo et al. | May 2004 | B2 |
6732800 | Acock et al. | May 2004 | B2 |
6745159 | Todd et al. | Jun 2004 | B1 |
6749025 | Brannon et al. | Jun 2004 | B1 |
6753299 | Longhofer et al. | Jun 2004 | B2 |
6763888 | Harris et al. | Jul 2004 | B1 |
6764981 | Eoff et al. | Jul 2004 | B1 |
6766858 | Nguyen et al. | Jul 2004 | B2 |
6776235 | England | Aug 2004 | B1 |
6776236 | Nguyen | Aug 2004 | B1 |
6920929 | Nguyen et al. | Sep 2004 | B2 |
6817414 | Lee | Nov 2004 | B2 |
6830105 | Thesing | Dec 2004 | B2 |
6832650 | Nguyen et al. | Dec 2004 | B2 |
6832655 | Ravensbergen et al. | Dec 2004 | B2 |
6837309 | Boney et al. | Jan 2005 | B2 |
6840318 | Lee et al. | Jan 2005 | B2 |
6851474 | Nguyen | Feb 2005 | B2 |
6852173 | Banerjee et al. | Feb 2005 | B2 |
6861394 | Ballard et al. | Mar 2005 | B2 |
6866099 | Nguyen | Mar 2005 | B2 |
6877560 | Nguyen et al. | Apr 2005 | B2 |
6881709 | Nelson et al. | Apr 2005 | B2 |
6887834 | Nguyen et al. | May 2005 | B2 |
6892813 | Nguyen et al. | May 2005 | B2 |
6949491 | Cooke, Jr. | Sep 2005 | B2 |
6962200 | Nguyen et al. | Nov 2005 | B2 |
6978836 | Nguyen et al. | Dec 2005 | B2 |
6981560 | Nguyen et al. | Jan 2006 | B2 |
6997259 | Nguyen | Feb 2006 | B2 |
7007752 | Reddy et al. | Mar 2006 | B2 |
7013976 | Nguyen et al. | Mar 2006 | B2 |
7017665 | Nguyen | Mar 2006 | B2 |
7021379 | Nguyen et al. | Apr 2006 | B2 |
7025134 | Byrd et al. | Apr 2006 | B2 |
7028774 | Nguyen et al. | Apr 2006 | B2 |
7032667 | Nguyen et al. | Apr 2006 | B2 |
7036589 | Nguyen | May 2006 | B2 |
7040403 | Nguyen et al. | May 2006 | B2 |
7044220 | Nguyen et al. | May 2006 | B2 |
7049272 | Sinclair et al. | May 2006 | B2 |
7059406 | Nguyen | Jun 2006 | B2 |
7063150 | Slabaugh et al. | Jun 2006 | B2 |
7066258 | Justus et al. | Jun 2006 | B2 |
7073581 | Nguyen et al. | Jul 2006 | B2 |
7080688 | Todd et al. | Jul 2006 | B2 |
7081439 | Sullivan et al. | Jul 2006 | B2 |
7093658 | Chatterji et al. | Aug 2006 | B2 |
7104325 | Nguyen et al. | Sep 2006 | B2 |
7114560 | Nguyen et al. | Oct 2006 | B2 |
7114570 | Nguyen et al. | Oct 2006 | B2 |
7117942 | Dalrymple et al. | Oct 2006 | B2 |
7131491 | Blauch et al. | Nov 2006 | B2 |
7153575 | Anderson et al. | Dec 2006 | B2 |
7156194 | Nguyen | Jan 2007 | B2 |
7166560 | Still et al. | Jan 2007 | B2 |
7178596 | Blauch et al. | Feb 2007 | B2 |
7204311 | Welton et al. | Apr 2007 | B2 |
7210528 | Brannon et al. | May 2007 | B1 |
7211547 | Nguyen | May 2007 | B2 |
7216711 | Nguyen et al. | May 2007 | B2 |
7237609 | Nguyen | Jul 2007 | B2 |
7252146 | Slabaugh et al. | Aug 2007 | B2 |
7255169 | Van Batenburg et al. | Aug 2007 | B2 |
7261156 | Nguyen et al. | Aug 2007 | B2 |
7264051 | Nguyen et al. | Sep 2007 | B2 |
7264052 | Nguyen et al. | Sep 2007 | B2 |
7265079 | Willberg et al. | Sep 2007 | B2 |
7267171 | Dusterhoft et al. | Sep 2007 | B2 |
7267717 | Watanabe et al. | Sep 2007 | B2 |
7273099 | East, Jr. et al. | Sep 2007 | B2 |
7281580 | Nguyen et al. | Oct 2007 | B2 |
7281581 | Nguyen et al. | Oct 2007 | B2 |
7299875 | Nguyen et al. | Nov 2007 | B2 |
7306037 | Nguyen et al. | Dec 2007 | B2 |
7343973 | Dusterhoft et al. | Mar 2008 | B2 |
20010016562 | Muir et al. | Aug 2001 | A1 |
20020036088 | Todd | Mar 2002 | A1 |
20020043370 | Poe | Apr 2002 | A1 |
20020048676 | McDaniel et al. | Apr 2002 | A1 |
20020070020 | Nguyen | Jun 2002 | A1 |
20020104217 | Echols et al. | Aug 2002 | A1 |
20020160920 | Dawson et al. | Oct 2002 | A1 |
20020169085 | Miller et al. | Nov 2002 | A1 |
20020189808 | Nguyen et al. | Dec 2002 | A1 |
20030006036 | Malone et al. | Jan 2003 | A1 |
20030013871 | Mallon et al. | Jan 2003 | A1 |
20030060374 | Cooke, Jr. | Mar 2003 | A1 |
20030106690 | Boney et al. | Jun 2003 | A1 |
20030114314 | Ballard et al. | Jun 2003 | A1 |
20030114317 | Benton et al. | Jun 2003 | A1 |
20030130133 | Vollmer | Jul 2003 | A1 |
20030131999 | Nguyen et al. | Jul 2003 | A1 |
20030148893 | Lunghofer et al. | Aug 2003 | A1 |
20030186820 | Thesing | Oct 2003 | A1 |
20030188766 | Banerjee et al. | Oct 2003 | A1 |
20030188872 | Nguyen et al. | Oct 2003 | A1 |
20030196805 | Boney et al. | Oct 2003 | A1 |
20030205376 | Ayoub et al. | Nov 2003 | A1 |
20030230408 | Acock et al. | Dec 2003 | A1 |
20030230431 | Reddy et al. | Dec 2003 | A1 |
20030234103 | Lee et al. | Dec 2003 | A1 |
20040000402 | Nguyen et al. | Jan 2004 | A1 |
20040014607 | Sinclair et al. | Jan 2004 | A1 |
20040014608 | Nguyen et al. | Jan 2004 | A1 |
20040040706 | Hossaini et al. | Mar 2004 | A1 |
20040040708 | Stephenson et al. | Mar 2004 | A1 |
20040040712 | Ravi et al. | Mar 2004 | A1 |
20040040713 | Nguyen et al. | Mar 2004 | A1 |
20040043906 | Heath et al. | Mar 2004 | A1 |
20040045712 | Eoff et al. | Mar 2004 | A1 |
20040048752 | Nguyen et al. | Mar 2004 | A1 |
20040055747 | Lee | Mar 2004 | A1 |
20040060702 | Kotlar et al. | Apr 2004 | A1 |
20040106525 | Willberg et al. | Jun 2004 | A1 |
20040138068 | Rimmer et al. | Jul 2004 | A1 |
20040149441 | Nguyen et al. | Aug 2004 | A1 |
20040152601 | Still et al. | Aug 2004 | A1 |
20040152602 | Boles | Aug 2004 | A1 |
20040177961 | Nguyen et al. | Sep 2004 | A1 |
20040194961 | Nguyen et al. | Oct 2004 | A1 |
20040206499 | Nguyen et al. | Oct 2004 | A1 |
20040211559 | Nguyen et al. | Oct 2004 | A1 |
20040211561 | Nguyen et al. | Oct 2004 | A1 |
20040221992 | Nguyen et al. | Nov 2004 | A1 |
20040231845 | Cooke, Jr. | Nov 2004 | A1 |
20040231847 | Nguyen et al. | Nov 2004 | A1 |
20040256097 | Byrd et al. | Dec 2004 | A1 |
20040256099 | Nguyen et al. | Dec 2004 | A1 |
20040261993 | Nguyen | Dec 2004 | A1 |
20040261995 | Nguyen et al. | Dec 2004 | A1 |
20040261997 | Nguyen et al. | Dec 2004 | A1 |
20040261999 | Nguyen | Dec 2004 | A1 |
20050000694 | Dalrymple et al. | Jan 2005 | A1 |
20050000731 | Nguyen et al. | Jan 2005 | A1 |
20050006093 | Nguyen | Jan 2005 | A1 |
20050006095 | Justus et al. | Jan 2005 | A1 |
20050006096 | Nguyen et al. | Jan 2005 | A1 |
20050028976 | Nguyen | Feb 2005 | A1 |
20050028979 | Brannon et al. | Feb 2005 | A1 |
20050034862 | Nguyen | Feb 2005 | A1 |
20050034865 | Todd et al. | Feb 2005 | A1 |
20050045326 | Nguyen | Mar 2005 | A1 |
20050045330 | Nguyen et al. | Mar 2005 | A1 |
20050045384 | Nguyen | Mar 2005 | A1 |
20050051331 | Nguyen et al. | Mar 2005 | A1 |
20050051332 | Nguyen et al. | Mar 2005 | A1 |
20050059555 | Dusterhoft et al. | Mar 2005 | A1 |
20050061509 | Nguyen | Mar 2005 | A1 |
20050092489 | Welton et al. | May 2005 | A1 |
20050126780 | Todd et al. | Jun 2005 | A1 |
20050139359 | Maurer et al. | Jun 2005 | A1 |
20050145385 | Nguyen | Jul 2005 | A1 |
20050173116 | Nguyen et al. | Aug 2005 | A1 |
20050178551 | Tolman et al. | Aug 2005 | A1 |
20050194135 | Nguyen et al. | Sep 2005 | A1 |
20050194136 | Nguyen et al. | Sep 2005 | A1 |
20050194140 | Dalrymple et al. | Sep 2005 | A1 |
20050194142 | Nguyen | Sep 2005 | A1 |
20050197258 | Nguyen | Sep 2005 | A1 |
20050207001 | Laufer et al. | Sep 2005 | A1 |
20050257929 | Nguyen et al. | Nov 2005 | A1 |
20050263283 | Nguyen | Dec 2005 | A1 |
20050267001 | Weaver et al. | Dec 2005 | A1 |
20050269086 | Nguyen et al. | Dec 2005 | A1 |
20050269101 | Stegent et al. | Dec 2005 | A1 |
20050274510 | Nguyen et al. | Dec 2005 | A1 |
20050274517 | Blauch et al. | Dec 2005 | A1 |
20050274520 | Nguyen et al. | Dec 2005 | A1 |
20050277554 | Blauch et al. | Dec 2005 | A1 |
20050284632 | Dalrymple et al. | Dec 2005 | A1 |
20050284637 | Stegent et al. | Dec 2005 | A1 |
20060048943 | Parker et al. | Mar 2006 | A1 |
20060048944 | van Batenburg et al. | Mar 2006 | A1 |
20060052251 | Anderson et al. | Mar 2006 | A1 |
20060089266 | Dusterhoft et al. | Apr 2006 | A1 |
20060113078 | Nguyen et al. | Jun 2006 | A1 |
20060124303 | Nguyen et al. | Jun 2006 | A1 |
20060124309 | Nguyen et al. | Jun 2006 | A1 |
20060137875 | Dusterhoft et al. | Jun 2006 | A1 |
20060157243 | Nguyen | Jul 2006 | A1 |
20060175058 | Nguyen | Aug 2006 | A1 |
20060219405 | Nguyen et al. | Oct 2006 | A1 |
20060219408 | Nguyen et al. | Oct 2006 | A1 |
20060234874 | Eoff et al. | Oct 2006 | A1 |
20060240994 | Eoff et al. | Oct 2006 | A1 |
20060240995 | Rickman et al. | Oct 2006 | A1 |
20060260810 | Weaver et al. | Nov 2006 | A1 |
20060260813 | Welton et al. | Nov 2006 | A1 |
20060264332 | Welton et al. | Nov 2006 | A1 |
20060266522 | Eoff et al. | Nov 2006 | A1 |
20060283592 | Sierra et al. | Dec 2006 | A1 |
20060289160 | van Batenburg et al. | Dec 2006 | A1 |
20070007010 | Welton et al. | Jan 2007 | A1 |
20070012445 | Nguyen et al. | Jan 2007 | A1 |
20070029087 | Nguyen et al. | Feb 2007 | A1 |
20070114032 | Stegent et al. | May 2007 | A1 |
20070131422 | Gatlin et al. | Jun 2007 | A1 |
20070131425 | Gatlin et al. | Jun 2007 | A1 |
20070187097 | Weaver et al. | Aug 2007 | A1 |
20070215354 | Rickman et al. | Sep 2007 | A1 |
20070267194 | Nguyen et al. | Nov 2007 | A1 |
20080006405 | Rickman et al. | Jan 2008 | A1 |
20080006406 | Nguyen et al. | Jan 2008 | A1 |
20080110624 | Nguyen et al. | May 2008 | A1 |
20090151943 | Nguyen | Jun 2009 | A1 |
Number | Date | Country |
---|---|---|
2063877 | Sep 1992 | CA |
0313243 | Apr 1989 | EP |
0506934 | Oct 1992 | EP |
0510762 | Nov 1992 | EP |
0528595 | Feb 1993 | EP |
0643196 | Mar 1995 | EP |
0834644 | Apr 1998 | EP |
0853186 | Jul 1998 | EP |
0864726 | Sep 1998 | EP |
0879935 | Nov 1998 | EP |
0933498 | Aug 1999 | EP |
1001133 | May 2000 | EP |
1132569 | Sep 2001 | EP |
1326003 | Jul 2003 | EP |
1362978 | Nov 2003 | EP |
1394355 | Mar 2004 | EP |
1396606 | Mar 2004 | EP |
1398460 | Mar 2004 | EP |
1403466 | Mar 2004 | EP |
1464789 | Oct 2004 | EP |
1607572 | Dec 2005 | EP |
1107584 | Mar 1968 | GB |
1264180 | Feb 1972 | GB |
1292718 | Oct 1972 | GB |
2298440 | Sep 1996 | GB |
2382143 | May 2003 | GB |
WO 9315127 | Aug 1993 | WO |
WO 9407949 | Apr 1994 | WO |
WO 9408078 | Apr 1994 | WO |
WO 9408090 | Apr 1994 | WO |
WO 9509879 | Apr 1995 | WO |
WO 9711845 | Apr 1997 | WO |
WO 9927229 | Jun 1999 | WO |
WO 0187797 | Nov 2001 | WO |
WO 0181914 | Nov 2001 | WO |
WO 0212674 | Feb 2002 | WO |
WO 03027431 | Apr 2003 | WO |
WO 2004009956 | Jan 2004 | WO |
WO 2004037946 | May 2004 | WO |
WO 2004038176 | May 2004 | WO |
WO 2004083600 | Sep 2004 | WO |
WO 2004090281 | Oct 2004 | WO |
WO 2004104368 | Dec 2004 | WO |
WO 2005021928 | Mar 2005 | WO |
WO 2005080749 | Sep 2005 | WO |
WO 2006116868 | May 2006 | WO |
WO 2006103385 | Oct 2006 | WO |
WO 2007091007 | Aug 2007 | WO |
WO 2007091058 | Aug 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20070187097 A1 | Aug 2007 | US |